Bioorganic and Medicinal Chemistry Letters p. 2467 - 2472 (1998)
Update date:2022-08-05
Topics:
Nerenberg, Jennie B.
Erb, Jill M.
Thompson, Wayne J.
Lee, Hee-Yoon
Guare, James P.
Munson, Peter M.
Bergman, Jeffrey M.
Huff, Joel R.
Broten, Theodore P.
Chang, Raymond S. L.
Chen, Tsing B.
O'Malley, Stacey
Schorn, Terry W.
Scott, Ann L.
Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect
View MoreHubei Xinghuo Chemical Co., Ltd.,
Contact:13925817279 13907299441
Address:Xinghuo Fine Chemistry Industrial Park, Xiaochang County, Hubei Province, China
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Doi:10.1021/jo01271a045
(1968)Doi:10.1039/DT9950001857
(1995)Doi:10.1248/cpb.15.1331
(1967)Doi:10.1039/j39670002700
(1967)Doi:10.1016/S0040-4039(00)72432-4
(1973)Doi:10.1016/0957-4166(95)00201-Y
(1995)
